Zydus Cadila Gets Emergency Use Nod For Virafin To Treat Average Covid-19

(The DRDO is listed as the trial’s major sponsor and Dr Reddy’s the secondary.) However, the CTRI registration of this trial does not point out which parameters the trial researchers plan to measure. This image, which the federal government shared in a press launch, reveals that cell cultures in a laboratory without 2-DG had extra...